SCHEMBL18724876

SCHEMBL18724876

Cn1nc(C(=O)N[C@H](Cc2ccc(-c3cccc(Cl)c3)cc2)CC(O)C(=O)O)cc1O

nearest known ligand 0.70

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 20/20 0.70
▸ ACE P12821 5/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9930536 1.00 MME (0.70) MMEACE
SCHEMBL17011170 0.91 MME (0.58) MMEACE
SCHEMBL18724854 0.91 MME (0.58) MMEACE
SCHEMBL17011174 0.90 MME (0.60) MMEACE
SCHEMBL9930294 0.89 MME (0.77) MMEACE
SCHEMBL9930506 0.89 MME (0.68) MMEACE
SCHEMBL17011180 0.87 ACE (0.59) MMEACE
SCHEMBL18724754 0.87 ACE (0.59) MMEACE
SCHEMBL19708615 0.86 MME (0.64) MMEACE
SCHEMBL18724848 0.86 MME (0.53) MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3199517-A1 NEPRILYSIN INHIBITORS Theravance Biopharma R&D IP, LLC (US) 2017-08-02 — — EP disclosed
EP-2864292-B1 NEPRILYSIN INHIBITORS THERAVANCE BIOPHARMA R&D IP LLC (US) 2017-04-12 — — EP disclosed
Send feedback